General Information of Drug (ID: DMWK951)

Drug Name
MLN7243 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
71715374
TTD Drug ID
DMWK951

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ubiquitin-activating enzyme (UBA) TTU8HT1 NOUNIPROTAC Modulator [2]

References

1 ClinicalTrials.gov (NCT02045095) A Phase 1, Dose Escalation Study of MLN7243 in Adult Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 757275).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)